Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies.
Shiohara M, Spirin K, Said JW, Gombart AF, Nakamaki T, Takeuchi S, Hatta Y, Morosetti R, Tasaka T, Seriu T, Bartram C, Miller CW, Tomonaga M, Koeffler HP.
Shiohara M, et al. Among authors: bartram c.
Leukemia. 1996 Dec;10(12):1897-900.
Leukemia. 1996.
PMID: 8946928